dicrotyl ether | 7023-45-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: dicrotyl ether
• 英文别名: di-but-2t-enyl ether；di-but-2-enyl ether；Di-β-butenyl-aether；Di-but-2-enyl-aether；Dicrotylaether；crotyl ether；(E)-1-[(E)-but-2-enoxy]but-2-ene
• CAS: 7023-45-2
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: FXCXOKOKILDXCL-GGWOSOGESA-N

物化性质

• 沸点：
  59-60 °C(Press: 14 Torr)
• 密度：
  0.818±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  dicrotyl ether 在 正丁基锂 作用下， 以 四氢呋喃 为溶剂， 以70%的产率得到(threo)-trans-3-methyl-1,5-hexadien-4-ol
  参考文献：
  名称：

  Tomooka, Katsuhiko; Wei, Shih-Yi; Nakai, Takeshi, Chemistry Letters, 1991, # 1, p. 43 - 46

  摘要：

  DOI：
• 作为产物：
  描述：

  巴豆醇 在 四(三苯基膦)钯 、 氧气 作用下， 以 甲苯 为溶剂， 生成 dicrotyl ether
  参考文献：
  名称：

  钯催化烯丙基醇氧化形成α，β-不饱和羰基化合物

  摘要：

  在氧气存在下用催化量的钯催化剂处理烯丙醇会导致形成α，β-不饱和羰基化合物。

  DOI：

  10.1016/0040-4039(94)88235-5

文献信息

• Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
  申请人：——

  公开号：US20040204368A1

  公开（公告）日：2004-10-14

  An oxadiazole derivative of formula (I) and a non-toxic salt thereof, 1 wherein all symbols have the same meaning as described in the specification. The compound of formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition of proteins which compose organism, shock, circulatory system disorders, blood coagulation system(s) disorders, malignant tumors, acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC), parasitic diseases, nerve degeneration diseases, pulmonary disorders, bone resorption diseases, endocrinesthenia, etc.

  公式（I）的一种噁二唑衍生物及其非毒性盐， 其中所有符号的含义与规范中描述的相同。公式（I）的化合物具有对半胱氨酸蛋白酶的抑制活性，因此它可用作预防和/或治疗炎症性疾病、由细胞凋亡引起的疾病、由免疫反应紊乱引起的疾病、自身免疫疾病、由构成生物体的蛋白质分解引起的疾病、休克、循环系统紊乱、血液凝固系统紊乱、恶性肿瘤、获得性免疫缺陷综合症（AIDS）和AIDS相关综合症（ARC）、寄生虫病、神经退行性疾病、肺部疾病、骨吸收疾病、内分泌亢进等方面的药剂。
• Organotins as etherification catalysts. III. Etherifications and hydro-hydroxy-eliminations promoted by butyltin trichloride
  作者：Daniele Marton、Pierangelo Slaviero、Giuseppe Tagliavini

  DOI：10.1016/s0040-4020(01)89178-x

  日期：——

  Butyltin trichloride, as a catalyst precursor, promotes the following processes: (i) etherification of 2,3-unsaturated alcohols, (ii) etherification of functional diols, (iii) cyclization of 2,5-hexanedione, and (iv) dehydration of cyclic diols. Many examples are reported.

  丁基锡三氯化物作为催化剂前体，可促进以下过程：（i）2,3-不饱和醇的醚化，（ii）功能性二醇的醚化，（iii）2,5-己二酮的环化和（iv）脱水环状二醇。报告了许多示例。
• Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
  申请人：——

  公开号：US20030166573A1

  公开（公告）日：2003-09-04

  An oxadiazole derivative of formula (I) and a non-toxic salt thereof, 1 wherein R is hydrogen, alkyl, CycA, etc.; AA 1 is a single bond, amino acid residue, etc.; AA 2 is a single bond, amino acid residue, etc.; R 7 and R 8 are hydrogen, alkyl, etc.; R 9 is hydrogen, alkyl, etc.; R 10 is hydrogen, alkyl, etc.). The compound of formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition of proteins which compose organism, shock, circulatory system disorders, blood coagulation system disorders, malignant tumors, acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC), parasitic diseases, nerve degeneration diseases, pulmonary disorders, bone resorption diseases, endocrinesthenia, etc.

  公式（I）的一种噁二唑衍生物及其非毒性盐，其中R为氢、烷基、环烷A等；AA1为单键、氨基酸残基等；AA2为单键、氨基酸残基等；R7和R8为氢、烷基等；R9为氢、烷基等；R10为氢、烷基等。公式（I）的化合物具有对半胱氨酸蛋白酶的抑制活性，因此它可用作预防和/或治疗炎症性疾病、细胞凋亡诱导的疾病、免疫反应紊乱诱导的疾病、自身免疫疾病、由组成生物体的蛋白质分解诱导的疾病、休克、循环系统紊乱、血液凝固系统紊乱、恶性肿瘤、获得性免疫缺陷综合症（AIDS）和AIDS相关综合症（ARC）、寄生虫病、神经退行性疾病、肺部疾病、骨吸收疾病、内分泌虚弱等方面的药物。
• [EN] AMINE-CONTAINING CYCLIC HYDROFLUOROETHERS AND METHODS OF USING THE SAME<br/>[FR] HYDROFLUOROÉTHERS CYCLIQUES CONTENANT UNE AMINE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：3M INNOVATIVE PROPERTIES CO

  公开号：WO2017155735A1

  公开（公告）日：2017-09-14

  Described herein is a cyclic fluorinated compound of formula (I) where: L is O, CH2, or a covalent bond; X is selected from F or CF3, and Y is selected from H, F, or CF3, wherein when X is CF3 then Y is F and when Y is CF3 then X is F„ each Rf1 is independently selected from a linear or branched perfluorinated alkyl group comprising 1-8 carbon atoms and optionally comprising at least one catenated atom selected from O, N, or combinations thereof; or the two Rf1 groups are bonded together to form a fluorinated ring structure comprising 4-8 carbon atoms and optionally comprising at least one catenated atom selected from O, N, or combinations thereof; the -CFZ-CHAQ group is bonded to a ring carbon that is alpha to at least one O atom of the ring; A is selected from F, or CF3; Z is selected from H, F, or CF3; and Q is selected from (i) a F atom, (ii) a Cl atom, (iii) a linear, cyclic, or branched perfluorinated alkyl group comprising 1-8 carbon atoms and optionally comprising at least one catenated atom selected from O, N, or combinations thereof, or (iv) a G(Rf2)e group, where G is an O atom or a N atom wherein: when Q is a Cl atom, then Z and A are F atoms; when G is O then e is 1, Z is H, F, or CF3; A is F; and Rf2 is a linear or branched perfluorinated alkyl group comprising 1-10 carbon atoms and optionally comprising at least one catenated atom selected from O, N, or combinations thereof; when G is N then e is 2, and each Rf2 group is independently a linear or branched perfluorinated alkyl group comprising 1-8 carbon atoms and optionally comprising at least one catenated atom selected from O, N, or combinations thereof or the two Rf2 groups are bonded together to form a fluorinated ring structure comprising 4-8 carbon atoms and optionally comprising at least one catenated atom selected from O, N, or combinations thereof, with the proviso that when A is CF3 then Z is F, and when Z is CF3 then A is F.

  本文描述的是一个循环氟化合物，其化学式为(I)，其中：L为O、CH2或共价键；X从F或CF3中选择，Y从H、F或CF3中选择，当X为CF3时，Y为F，当Y为CF3时，X为F；每个Rf1独立地选择自由1-8个碳原子的线性或支链全氟烷基基团，并且可选地包含至少一个由O、N或其组合选择的连结原子；或两个Rf1基团结合在一起形成含有4-8个碳原子并且可选地包含至少一个由O、N或其组合选择的连结原子的氟化环结构；-CFZ-CHAQ基团与环的至少一个O原子的α位碳原子结合；A从F或CF3中选择；Z从H、F或CF3中选择；Q从(i)F原子、(ii)Cl原子、(iii)线性、环状或支链全氟烷基基团，包括1-8个碳原子，并且可选地包含至少一个由O、N或其组合选择的连结原子，或(iv)G(Rf2)e基团中选择，其中G为O原子或N原子，当Q为Cl原子时，Z和A为F原子；当G为O时，e为1，Z为H、F或CF3，A为F，Rf2为包括1-10个碳原子的线性或支链全氟烷基基团，并且可选地包含至少一个由O、N或其组合选择的连结原子；当G为N时，e为2，每个Rf2基团独立地选择自由1-8个碳原子的线性或支链全氟烷基基团，并且可选地包含至少一个由O、N或其组合选择的连结原子，或两个Rf2基团结合在一起形成含有4-8个碳原子并且可选地包含至少一个由O、N或其组合选择的连结原子的氟化环结构，但A为CF3时，Z为F，Z为CF3时，A为F。
• Electrophilic assistance for cross-coupling reactions: A simple sythesis of mixed allylic ethers
  作者：Antonella De Mico、Roberto Margarita、Giovanni Piancatelli

  DOI：10.1016/0040-4039(95)00332-7

  日期：1995.4

  Magnesium perchlorate, acting as a mild Lewis acid, is an efficient reagent for the synthesis of unsymmetrical ethers from allylic alcohols.

  高氯酸镁作为一种温和的路易斯酸，是从烯丙基醇合成不对称醚的有效试剂。